ADHD Study for Children – Stimulant

Jornay vs Placebo

$85 per completed visit

Study Specific Details:

  • Jornay vs Placebo – this is a a randomized, double-blind, parallel-group, placebo-controlled study. Dr. Handal will be able to find out medication the subject is on in case of emergency.
  • Entire study is about 2 months (6 total visits) with 4 weekly visits and an end of study visit. 
  • Participants are reimbursed $85 for their time and travel at the end of each completed visit.
  • Inclusion
  • Exclusion
  • Male or Female ages 4-5.
  • Must meet DSM-5 criteria for a primary diagnosis of ADHD based on a psychiatric evaluation using the MINI-KID.
  • Height and weight must be between the 5th and 95th percentile for age and gender.  
  • Must have undergone an adequate course of nonpharmacologic treatment or has a severe enough condition in the opinion of the investigator to consider enrollment prior to nonpharmacologic treatment. 
  • Initiation of Cognitive Behavioral Therapy within 30 days prior to baseline. 
  • Oppositional defiant disorder (ODD) is allowed as long as it is not the primary focus of treatment.   
  • Mood disorder is at the discretion of the PI. 
  • Any diagnosis of psychosis, bipolar, major depressive disorder, anxiety disorder, eating disorder, conduct disorder, or OCD
  • History of psychosis, autism, tic disorder, disruptive mood dysregulation disorder, intellectual disability, Tourette's Syndrome, confirmed genetic disorder with cognitive and/or behavioral disturbances.
  • History of seizure disorder (except febrile seizures prior to age 4 and with the last occurrence at least 1 year prior to study participation). 
  • Patient is considered to be at risk of suicide. 
Questions? Give Us A Call!

Contact Us

Want to learn more about Harmonex Neuroscience Research?